KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Asset Utilization Ratio (2016 - 2026)

Pfizer has reported Asset Utilization Ratio over the past 18 years, most recently at 0.12 for Q1 2026.

  • Quarterly Asset Utilization Ratio fell 19.34% to 0.12 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.12 through Mar 2026, down 19.34% year-over-year, with the annual reading at 0.3 for FY2025, 666.08% up from the prior year.
  • Asset Utilization Ratio was 0.12 for Q1 2026 at Pfizer, up from 0.12 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.67 in Q4 2022 and troughed at 0.03 in Q3 2025.
  • The 5-year median for Asset Utilization Ratio is 0.15 (2024), against an average of 0.23.
  • Year-over-year, Asset Utilization Ratio plummeted 91.78% in 2023 and then soared 166.17% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.67 in 2022, then crashed by 91.7% to 0.06 in 2023, then soared by 166.21% to 0.15 in 2024, then decreased by 20.98% to 0.12 in 2025, then rose by 1.17% to 0.12 in 2026.
  • Per Business Quant, the three most recent readings for PFE's Asset Utilization Ratio are 0.12 (Q1 2026), 0.12 (Q4 2025), and 0.03 (Q3 2025).